Trial intelligence / Profile preview

Neoadjuvant Docetaxel in Advanced Cervical Carcinoma

NCT00003445Phase 2Completed

Sponsor
Grupo Oncológico Cooperativo del Sur
Start
Dec 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in Cervical Cancer (CC), sponsored by Grupo Oncológico Cooperativo del Sur. Started Dec 1997; status: completed.

02

Drugs

docetaxel
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00003445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call